Summary
All listed iron–atorvastatin interaction, absorption, quantitative magnitude, dietary food-content, and timing separation claims are not supported by the provided FDA label excerpts (which contain no iron-related interaction or administration timing guidance).
Category Scores
Accurate Statements
Unsupported Statements
Iron and atorvastatin can bind together in the gastrointestinal tract.
No support in the provided FDA label excerpts.
When iron and atorvastatin bind, less atorvastatin is absorbed.
No support in the provided FDA label excerpts.
Reduced atorvastatin absorption can lower atorvastatin blood levels.
No support in the provided FDA label excerpts.
Lower atorvastatin blood levels can reduce its cholesterol-lowering effect.
No support in the provided FDA label excerpts.
Iron supplements (e.g., ferrous sulfate 325 mg providing 65–100 mg elemental iron) can significantly reduce atorvastatin absorption.
No support in the provided FDA label excerpts.
Iron supplements can reduce absorption by up to about 25–40%.
No support in the provided FDA label excerpts.
Iron-fortified multivitamins (10–18 mg elemental iron) can cause a mild to moderate reduction in atorvastatin absorption.
No support in the provided FDA label excerpts.
Plant foods (beans, spinach, fortified cereals) typically contain 1–10 mg elemental iron per serving.
No support in the provided FDA label excerpts.
Iron from most plant foods usually has a modest impact on atorvastatin absorption.
No support in the provided FDA label excerpts.
Some studies show less than a 10% impact for iron from plant foods, depending on total meal iron load and gut iron status.
No support in the provided FDA label excerpts.
Heme iron from meat (2–5 mg per 100 g) generally causes less interference because heme iron is absorbed differently.
No support in the provided FDA label excerpts.
Iron can interact with Lipitor (atorvastatin) by reducing its absorption.
No support in the provided FDA label excerpts.
The iron–Lipitor interaction is strongest with iron supplements or very iron-dense meals.
No support in the provided FDA label excerpts.
Taking Lipitor on an empty stomach (at least 2 hours before or after meals) or at bedtime, as directed, is recommended.
No support in the provided FDA label excerpts. The provided excerpts include only a statement that patients should adhere to their medication and diet and do not provide administration timing rules.
If taking an iron supplement or eating a high-iron meal, waiting at least 2 hours before taking Lipitor or taking Lipitor 2 hours after the iron is recommended.
No support in the provided FDA label excerpts.
Contradictions
Important Omissions
FDA label-based guidance regarding iron/atorvastatin interactions (e.g., whether iron affects absorption, any quantification, and any recommended timing separation) and any FDA label-based administration instructions (including empty-stomach or bedtime timing specifics).
Importance:
High
Safety Assessment
Potential Patient Risk:
High
The response provides multiple specific interaction and timing recommendations that are not supported by the provided FDA label excerpts. Unsupported timing advice could lead to inappropriate administration practices relative to on-label directions.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Iron–atorvastatin interaction, quantitative effect estimates, food-content/diet impact, and 2-hour timing separation instructions are entirely unsupported by the provided FDA label excerpts.
Suggested Improvement
Remove or qualify all iron/absorption/timing claims unless supported by the relevant on-label sections; limit statements to what the FDA label excerpts provided actually cover (e.g., concomitant drug interaction warnings for other listed agents and general patient counseling).